Status:
COMPLETED
Comparative Study of Ceftaroline vs. Ceftriaxone in Adult Subjects With Community-Acquired Pneumonia
Lead Sponsor:
Forest Laboratories
Conditions:
Bacterial Pneumonia
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
The purpose of this study is to determine whether ceftaroline is effective and safe in the treatment of Community-Acquired Pneumonia
Detailed Description
The purpose of this study is to determine whether ceftaroline is effective and safe in the treatment of Community-Acquired Pneumonia. Clinical trials for this study is held in many countries
Eligibility Criteria
Inclusion
- Subjects are required to meet the following inclusion criteria:
- Community-acquired pneumonia
- initial hospitalization, or treatment in an emergency room or urgent care setting
- infection would require initial treatment with IV antimicrobials.
Exclusion
- Subjects must NOT meet any of the following exclusion criteria:
- CAP suitable for outpatient therapy with an oral antimicrobial agent
- respiratory tract infections not due to community-acquired bacterial
- Non-infectious causes of pulmonary infiltrates
- Pleural empyema
- Infection with an atypical organism
- History of any hypersensitivity or allergic reaction to any ß-lactam antimicrobial
- History of any hypersensitivity or allergic reaction to clarithromycin or any macrolide/ ketolide
Key Trial Info
Start Date :
January 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2009
Estimated Enrollment :
606 Patients enrolled
Trial Details
Trial ID
NCT00621504
Start Date
January 1 2008
End Date
June 1 2009
Last Update
March 14 2017
Active Locations (168)
Enter a location and click search to find clinical trials sorted by distance.
1
Investigational site
Los Angeles, California, United States, 90015
2
Investigational Site
Pasadena, California, United States, 91105
3
Investigational Site
Sacramento, California, United States, 95817
4
Investigational Site
San Diego, California, United States, 92114